Skip to content
Search

Latest Stories

#SaveOurPharmacies Campaign: NPA calls second Day of Action in support of cross-sector

#SaveOurPharmacies Campaign: NPA calls second Day of Action in support of cross-sector
The previous #SaveOurPharmacies campaign saw 6000 pharmacies across the four nations participate 

A second day of action has been announced by the National Pharmacy Association (NPA) to support the cross-sector #SaveOurPharmacies campaign.

This campaign aims to bring attention to the severe financial challenges facing community pharmacies due to ongoing cuts.


Scheduled for September 19, the day of action coincides with the political party conference season, aiming to emphasise the urgent need for government intervention to ensure continued patient access to pharmacies.

The NPA’s initiative follows the successful One Day to #SaveOurPharmacies event in June.

Approximately 6,000 pharmacies participated by dimming their lights, wearing black, and engaging on social media to spotlight the issues facing the sector.

The June event marked the first UK-wide protest of its kind for community pharmacies, garnering widespread support from independent pharmacies of all sizes.

The campaign’s petition has since amassed over 160,000 signatures, with more being added daily, showcasing the public's strong support for the cause.

Paul Rees, Chief Executive of the NPA, emphasised the association's commitment to consulting widely across the sector to plan impactful yet safe actions for the upcoming day of protest.

"We are absolutely committed to working hand in hand with whoever forms the next government – and colleagues across the sector - to deliver a better deal for community pharmacies and unleash the power of our network to cut GP and hospital waiting times for million," Rees stated.

He also highlighted the pressing need for proper funding to alleviate the financial crisis that has led to the closure of over 1,400 pharmacies in the past decade.

"We do hope that the ministerial team, whoever they are after the election, will seize the opportunity to invest in our network and help ease the dreadful waiting times for GP and hospital appointments.

"But we must ask our members to save the date and give ourselves a fresh moment to make it crystal clear that our network needs urgent support if it is to help deliver for patients across the UK," Rees added.

More For You

PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less